India Considers Easing Price-Hike Limits On Drugs
This article was originally published in PharmAsia News
Executive Summary
Indian authorities are considering an increase in the price caps on 70 scheduled drugs as drug makers plead for relief from their rising manufacturing expenses, such as the high price of ingredients from China. Also under consideration by the chemicals ministry and the drug price regulator is suspension of the annual 10 percent limit on price increases for drugs not under direct control. The plan includes revising the prices of several bulk drugs. Of the 70 scheduled drugs, 30 are imports by multinational drug makers. (Click here for more